Gait Impairment
10
3
3
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.0%
1 terminated out of 10 trials
83.3%
-3.2% vs benchmark
20%
2 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Dopaminergic Dysfunction in Late-Life Depression
Clinical Investigation to Validate the Safety and Performance of the ABLE Kids Device in Pediatric Patients With Neurological Gait Disorders in a Clinical Setting
Vibrotactile Balance Belt Effect on Improving Gait
Robot-Assisted Gait Training vs Visual Feedback Balance Training in Stroke
Transcranial Direct Current Stimulation for Post-stroke Gait Rehab
BCI-Assisted SCS-EXS for Gait Optimization
Wii-Fit For Improving Activity, Gait And Balance In Alzheimer's Dementia
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
The Relationship Between Pain, Balance and Gait in People With Chronic Obstructive Pulmonary Disease
Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease